TechBio vs. Biotech—what’s real, what’s hype, and how GenAI is actually changing the lab.In this interview, Kavya Sharman, PhD (Founder & Managing Partner, Phase Capital) breaks down the true differences between techbio and biotech,…
Continue Reading
Anastasia Bystritskaya, Sr. Global Life Science Market Analyst at Thermo Fisher Scientific
We are entering an era where aging is no longer seen as a passive decline, but as a dynamic, measurable, and critically modifiable…
Continue Reading
Nicole Ventrone, Partner at Beghou
Pharma is embracing GPT-5, shifting AI from chatbot to enterprise agent as it accelerates productivity amid regulatory challenges.
Large pharmaceutical and biotech companies have spent the last couple of years running…
Continue Reading
What You Should Know:
– Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics announced the publication of foundational preclinical data in the peer-reviewed journal Cell Reports Medicine, the close of a $25M Series…
Continue Reading
What You Should Know:
– Sanofi Ventures has announced a significant $625M multi-year capital commitment from Sanofi, substantially increasing its total assets under management (AUM) to over $1.4B.
– The new capital injection into the evergreen…
Continue Reading
What You Should Know:
– EVERSANA and Waltz Health have announced a merger valued at $6B to form a unified healthcare platform that will redefine pharmaceutical commercialization and patient access.
– The merger combines Waltz Health’s…
Continue Reading
Thomas Kluz, Managing Director at Niterra Ventures
The most consequential shift in modern medicine isn’t happening inside hospitals or biotech labs. It’s happening inside medical simulation labs / training centers.
Drug development has long been marked…
Continue Reading
What You Should Know:
– Ryght AI, a leading AI clinical trial developer, today announced a partnership with Biorasi, a global clinical research organization (CRO) specializing in dermatology, oncology, neurology, and nephrology studies.
– The collaboration will bring advanced,…
Continue Reading
Image Credit: Mid-Year Healthcare Investment and Exits Report
What You Should Know:
– After a strong start to the year, the digital health sector experienced a significant pullback in Q2 2025, with deal volume declining to…
Continue Reading
Michael J. Reidy, a senior consultant at Interaction Associates that has more than 25 years of experience in consulting and responding to the learning needs of individuals & groups in the healthcare, biotech, financial services,…
Continue Reading
